A Novel Phenotype-Based Drug-Induced Liver Injury Causality Assessment Tool (DILI-CAT) Allows for Signal Confirmation in Early Drug Development
dc.contributor.author | Tillmann, Hans L. | |
dc.contributor.author | Hermann, Richard P. | |
dc.contributor.author | Rockey, Don C. | |
dc.contributor.author | Suzuki, Ayako | |
dc.contributor.author | Merz, Michael | |
dc.date.accessioned | 2022-11-02T18:13:47Z | |
dc.date.available | 2022-11-02T18:13:47Z | |
dc.date.issued | 2022 | |
dc.description.sponsorship | ECU/Wiley Open Access Read-and-Publish agreement | |
dc.identifier.doi | 10.1111/apt.16836 | |
dc.identifier.issn | 0269-2813 | |
dc.identifier.uri | http://hdl.handle.net/10342/11685 | |
dc.language.iso | en_US | en_US |
dc.subject | drug-induced liver injury | en_US |
dc.subject | causality assessment tool (DILI-CAT) | en_US |
dc.subject | SPORTIF, stroke prevention using an ORal thrombin inhibitor in atrial fibrillation | en_US |
dc.title | A Novel Phenotype-Based Drug-Induced Liver Injury Causality Assessment Tool (DILI-CAT) Allows for Signal Confirmation in Early Drug Development | en_US |
dc.type | Article | en_US |
ecu.journal.issue | 8 | en_US |
ecu.journal.name | Alimentary Pharmacology and Therapeutics | en_US |
ecu.journal.pages | 1028-1037 | en_US |
ecu.journal.volume | 55 | en_US |